Kidney cancer refers to renal cell carcinoma, of which renal clear cell carcinoma has the best prognosis and is relatively more curable than other types.
The abbreviation of renal cell carcinoma is renal carcinoma, and the pathologic types are divided into clear cell carcinoma, papillary cell carcinoma, smoky cell carcinoma, unclassified renal cell carcinoma, collecting duct carcinoma, renal medullary carcinoma, and genetically related renal carcinoma. The most common pathologic type of renal cancer is clear cell carcinoma, which accounts for about 70% to 80% of cases.
Clear cell carcinoma is the most common type of kidney cancer, and it is also the type of kidney cancer with the best prognosis, therefore, renal clear cell carcinoma is also one of the most curable pathologic types of kidney cancer.
However, it should be noted that good prognosis does not mean absolute cure. Five-year survival rate is commonly used in clinical practice to indicate the cure rate, and the cure rate of stage I renal cancer is about 95%. The cure rate of advanced renal clear cell carcinoma is decreasing, but the quality of life and survival rate can be improved through active treatment.
However, through active treatment, the quality of life can be improved and the survival rate can be prolonged. Kidney cancer patients are advised to actively seek medical treatment and under the guidance of doctors, standardized and individualized treatment can be carried out to improve the prognosis and prolong the survival period.